Taskin, Irmak Icen2024-08-042024-08-0420231551-38151551-3823https://doi.org/10.1080/15513815.2023.2197057https://hdl.handle.net/11616/101288Objective: We investigated a disintegrin and metalloproteinase with thrombospondin type 1 motif-12 (ADAMTS-12) levels in both fetal umbilical cord and maternal blood of pairs diagnosed with placenta accreta spectrum (PAS).Method: We analyzed ADAMTS-12 level by ELISA in 160 samples that included 30 control pairs (30 maternal and 30 umbilical cord serums), 20 pairs in the placenta previa (PP), and 30 pairs in the PAS group (30 maternal and 30 umbilical cord serums).Results: There were increased serum levels of ADAMTS-12 in maternal serum (p = 0.037) and umbilical cord serum level (p = 0.004) of PAS group compared with the PP and healthy control groups. There was a positive correlation between maternal ADAMTS-12 and fetal ADAMTS-12 serum levels (r = 0.53, p = 0.002).Conclusion: Our findings indicate that ADAMTS-12 could be a -diagnostic biomarker for PAS.eninfo:eu-repo/semantics/closedAccessADAMTS-12maternal serumplacenta accreta spectrumumbilical cordArticle4246426503703947310.1080/15513815.2023.21970572-s2.0-85152385000Q3WOS:000969106000001Q4